Tay-Kearney, Mei-Ling

A/Prof Mei-Ling Tay-Kearney

Consultant Ophthalmologist; Lions Eye Institute, Royal Perth Hospital; Associate Professor, University of Western Australia
Associate Professor Mei-Ling Tay-Kearney is a consultant ophthalmologist at the LEI and Royal Perth Hospital. She specialises in infectious and autoimmune eye diseases and their treatments. She completed her ophthalmology training in Western Australia before undertaking postgraduate studies in ocular immunology and infections at the Wilmer Eye Institute at Johns Hopkins Hospital, Baltimore, USA.

Associate Professor Tay-Kearney has a strong commitment to professional education and training. She is an active member of the Royal Australian and New Zealand College of Ophthalmology (RANZCO) where she is a member of its Selection Board for Training, its Training Progression Committee, and a Training Hospital Inspector. She is also part of the LEI’s Medical Advisory Committee. She is active in Clinical Trials, focusing on new drug treatments for infectious and non-infectious ocular inflammation and continues to participate in tele-ophthalmology research.

Associate Professor Tay-Kearney has held various positions, including Head of Department at Royal Perth Hospital, RANZCO Advanced Clinical Examination (RACE) examiner and Qualification and Education Committee (QEC) Chair responsible for the ophthalmological training program in WA.

More from this expert

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.